Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection.

The mechanism for the pathogenesis of H5N1 infection in humans remains unclear. This study reveals that cyclooxygenase-2 (COX-2) was strongly induced in H5N1-infected macrophages in vitro and in epithelial cells of lung tissue samples obtained during autopsy of patients who died of H5N1 disease. Novel findings demonstrated that COX-2, along with tumor necrosis factor alpha and other proinflammatory cytokines were hyperinduced in epithelial cells by secretory factors from H5N1-infected macrophages in vitro. This amplification of the proinflammatory response is rapid, and the effects elicited by the H5N1-triggered proinflammatory cascade are broader than those arising from direct viral infection. Furthermore, selective COX-2 inhibitors suppress the hyperinduction of cytokines in the proinflammatory cascade, indicating a regulatory role for COX-2 in the H5N1-hyperinduced host proinflammatory cascade. These data provide a basis for the possible development of novel therapeutic interventions for the treatment of H5N1 disease, as adjuncts to antiviral drugs.

[1]  Jiang Gu,et al.  H5N1 infection of the respiratory tract and beyond: a molecular pathology study , 2007, The Lancet.

[2]  T. Tumpey,et al.  Highly Pathogenic Avian Influenza H5N1 Viruses Elicit an Attenuated Type I Interferon Response in Polarized Human Bronchial Epithelial Cells , 2007, Journal of Virology.

[3]  R. Webster,et al.  Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection , 2007, Proceedings of the National Academy of Sciences.

[4]  Yi Guan,et al.  Avian Influenza Virus (H5N1): a Threat to Human Health , 2007, Clinical Microbiology Reviews.

[5]  D. Garvey,et al.  Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers. , 2007, Current topics in medicinal chemistry.

[6]  A. Rodloff,et al.  Acute Respiratory Distress Syndrome and Pneumonia: A Comprehensive Review of Clinical Data , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  Yi Guan,et al.  Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia , 2006, Nature Medicine.

[8]  Yi Guan,et al.  Oseltamivir resistance during treatment of influenza A (H5N1) infection. , 2005, The New England journal of medicine.

[9]  D. Zeldin,et al.  Contrasting Effects of Cyclooxygenase-1 (COX-1) and COX-2 Deficiency on the Host Response to Influenza A Viral Infection1 , 2005, The Journal of Immunology.

[10]  Y. Guan,et al.  Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells , 2005, Respiratory research.

[11]  Angus Nicoll,et al.  Avian influenza A (H5N1) infection in humans. , 2005, The New England journal of medicine.

[12]  J. Nicholls,et al.  Influenza A H5N1 Replication Sites in Humans , 2005, Emerging infectious diseases.

[13]  Y. Guan,et al.  Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia , 2004, Nature.

[14]  J. Peiris,et al.  Re-emergence of fatal human influenza A subtype H5N1 disease , 2004, The Lancet.

[15]  S. Moochhala,et al.  Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome , 2004, The Journal of pathology.

[16]  J. Clària.  Cyclooxygenase-2 biology. , 2003, Current pharmaceutical design.

[17]  K. Wada,et al.  Monocyte chemoattractant protein 1 (MCP-1) released from Helicobacter pylori stimulated gastric epithelial cells induces cyclooxygenase 2 expression and activation in T cells , 2003, Gut.

[18]  Jonathan Cohen.  The immunopathogenesis of sepsis , 2002, Nature.

[19]  Y. Guan,et al.  Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? , 2002, The Lancet.

[20]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[21]  R. Sung,et al.  Pathology of fatal human infection associated with avian influenza A H5N1 virus , 2001, Journal of medical virology.

[22]  S. Vasoo,et al.  New cyclooxygenase inhibitors. , 2001, Annals of the Academy of Medicine, Singapore.

[23]  J. van Ryn,et al.  COX-2 selectivity and inflammatory processes. , 2000, Current medicinal chemistry.

[24]  A. Knox,et al.  TGF-β1 stimulates IL-8 release, COX-2 expression, and PGE2release in human airway smooth muscle cells , 2000 .

[25]  G. Mann,et al.  Induction of cyclooxygenase‐2 expression in human myometrial smooth muscle cells by interleukin‐1β: involvement of p38 mitogen‐activated protein kinase , 1999 .

[26]  M. Peiris,et al.  Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus , 1998, The Lancet.

[27]  K. Seibert,et al.  Mediation of inflammation by cyclooxygenase-2. , 1995, Agents and actions. Supplements.